Skip to content
  • en
  • ms

  • NADA Profile
    • Corporate Info
      • Message from The Director General of National Anti-Drugs Agency (NADA)
      • Top Management
      • Chief Information Officer (CIO)
      • About NADA
      • History Of NADA
      • Vision, Mission and Objectives
      • Client’s Charter
      • Client Charter Achievement Report
    • Policies, Acts & Circulars
      • Drugs-Related Act
      • NADA Financial Management Guidelines
      • ICT Management Circulars and Policies
      • Anti-Drug Agency Training Policy (DLAADK)
      • AADK Disciplinary Management Guide
      • Organizational Anti-Corruption Plan (OACP) AADK 2020-2024
      • NADA Anti-Corruption Policy
    • Divisions And Units
      • Treatment, Medicational And Rehabilitation Division
      • Enforcement And Security Division
      • Management Service Division
      • Information Technology And Communication Division
      • Policy, Planning And Research Division
      • Legal Advisory Unit
      • Media And Corporate Communication Unit
      • International Unit
      • Integrity Unit
      • MGDN Secretariat Unit
      • NADA Training Centre
    • Directory
      • Headquarter
      • NADA State Office
      • NADA District Office
      • Rehabilitation Centre
      • NADA Service Centre
      • Community House
      • Client Integration Centre (CIC)
      • Anti-Drugs Border Unit (UAS)
      • NADA Training Centre
  • Services
    • Treatment & Rehabilitation
      • Institution Based Treatment And Rehabilitation
      • Community Based Treatment And Rehabilitation
      • NADA’s Tele Hello
      • NADA Products
    • Prevention
      • Public Awareness and Anti-Drugs Campaigns
      • High Risk Areas Of Drugs Addiction
      • Drugs Free Family
      • Drug Free Educational Institutions
      • Drugs Free Workplace
      • Drugs Free Community
    • Enforcement
      • Complaints on Drug Problems
      • Hotline Operations Center (PGH)
      • Compliance with the Person Under Surveillance
  • Public
    • General
      • Advertisement/Tender and Quotation Statement
      • Drugs Statistics
      • NADA Research Grant
      • Federal Government Gazette
      • List of Private Drugs Rehabilitation Centers
      • Complaints and Feedback
      • NADA Integrity Complaint
      • e-Participation Policy
    • Online Services
      • Application for Anti-Drugs SKUAD Membership
      • Application for Anti-Drugs Exhibition
      • e-DrugNews
      • Library of AADK
      • The Malaysian Anti-Drugs Journal
    • Media & Publishing
      • AADK TV
      • Infographic
      • Informations On Drugs
      • Annual Report
      • Publishing
      • Integrity Lens
      • NADA Scientific Research Study
    • FAQ
      • FAQ : Enforcement And Security
      • FAQ : Pusat Pemulihan Penagihan Narkotik (PUSPEN)
      • FAQ : NADA Service Centre
      • FAQ : Community House
      • FAQ : Client Integration Centre (CIC)
      • FAQ : Private Drug Rehabilitation Centre (PPDP)
      • FAQ : Antidrugs SKUAD
  • NADA Staff
    • Login
      • AADK Official Email
  • en
  • ms

  • NADA Profile
    • Corporate Info
      • Message from The Director General of National Anti-Drugs Agency (NADA)
      • Top Management
      • Chief Information Officer (CIO)
      • About NADA
      • History Of NADA
      • Vision, Mission and Objectives
      • Client’s Charter
      • Client Charter Achievement Report
    • Policies, Acts & Circulars
      • Drugs-Related Act
      • NADA Financial Management Guidelines
      • ICT Management Circulars and Policies
      • Anti-Drug Agency Training Policy (DLAADK)
      • AADK Disciplinary Management Guide
      • Organizational Anti-Corruption Plan (OACP) AADK 2020-2024
      • NADA Anti-Corruption Policy
    • Divisions And Units
      • Treatment, Medicational And Rehabilitation Division
      • Enforcement And Security Division
      • Management Service Division
      • Information Technology And Communication Division
      • Policy, Planning And Research Division
      • Legal Advisory Unit
      • Media And Corporate Communication Unit
      • International Unit
      • Integrity Unit
      • MGDN Secretariat Unit
      • NADA Training Centre
    • Directory
      • Headquarter
      • NADA State Office
      • NADA District Office
      • Rehabilitation Centre
      • NADA Service Centre
      • Community House
      • Client Integration Centre (CIC)
      • Anti-Drugs Border Unit (UAS)
      • NADA Training Centre
  • Services
    • Treatment & Rehabilitation
      • Institution Based Treatment And Rehabilitation
      • Community Based Treatment And Rehabilitation
      • NADA’s Tele Hello
      • NADA Products
    • Prevention
      • Public Awareness and Anti-Drugs Campaigns
      • High Risk Areas Of Drugs Addiction
      • Drugs Free Family
      • Drug Free Educational Institutions
      • Drugs Free Workplace
      • Drugs Free Community
    • Enforcement
      • Complaints on Drug Problems
      • Hotline Operations Center (PGH)
      • Compliance with the Person Under Surveillance
  • Public
    • General
      • Advertisement/Tender and Quotation Statement
      • Drugs Statistics
      • NADA Research Grant
      • Federal Government Gazette
      • List of Private Drugs Rehabilitation Centers
      • Complaints and Feedback
      • NADA Integrity Complaint
      • e-Participation Policy
    • Online Services
      • Application for Anti-Drugs SKUAD Membership
      • Application for Anti-Drugs Exhibition
      • e-DrugNews
      • Library of AADK
      • The Malaysian Anti-Drugs Journal
    • Media & Publishing
      • AADK TV
      • Infographic
      • Informations On Drugs
      • Annual Report
      • Publishing
      • Integrity Lens
      • NADA Scientific Research Study
    • FAQ
      • FAQ : Enforcement And Security
      • FAQ : Pusat Pemulihan Penagihan Narkotik (PUSPEN)
      • FAQ : NADA Service Centre
      • FAQ : Community House
      • FAQ : Client Integration Centre (CIC)
      • FAQ : Private Drug Rehabilitation Centre (PPDP)
      • FAQ : Antidrugs SKUAD
  • NADA Staff
    • Login
      • AADK Official Email
Agensi Antidadah Kebangsaan > 2022 > February > 18

February 18, 2022

Khabar Dari PTj

PROGRAM SAHABAT AKRAB JKPD INISIATIF AADK JASIN I Edition February 18th, 2022

INTEGRITY CORNER
  • NADA Anti-Corruption Policy
  • Statement of NADA Anti-Corruption Policy
  • Integrity Bulletin
  • National Anti-Corruption Plan 2019-2023
  • Organizational Anti-Corruption Plan (OACP) AADK 2020-2024
  • Integrity Lens
  • Integrity News
  • e – Integrity
  • NADA Integrity Complaint
  • NADA Anti-Corruption Policy
  • Statement of NADA Anti-Corruption Policy
  • Integrity Bulletin
  • National Anti-Corruption Plan 2019-2023
  • Organizational Anti-Corruption Plan (OACP) AADK 2020-2024
  • Integrity Lens
  • Integrity News
  • e – Integrity
  • NADA Integrity Complaint
DIVISIONS AND UNITS
  • Enforcement And Security Division
  • Prevention Division
  • Policy, Planning And Research Division
  • Management Service Division
  • Information Technology And Communication Division
  • Integrity Unit
  • International Unit
  • Legal Advisory Unit
  • Media And Corporate Communication Unit
  • MGDN Secretariat Unit
  • NADA Training Centre
  • Enforcement And Security Division
  • Prevention Division
  • Policy, Planning And Research Division
  • Management Service Division
  • Information Technology And Communication Division
  • Integrity Unit
  • International Unit
  • Legal Advisory Unit
  • Media And Corporate Communication Unit
  • MGDN Secretariat Unit
  • NADA Training Centre
laman Web QRCode

NATIONAL ANTI-DRUGS AGENCY  MALAYSIA
MINISTRY OF HOME AFFAIRS
Jalan Maktab Perguruan Islam
43000 Kajang, Selangor

Tel : 03 – 8911 2200
Fax : 03 – 8926 2055
E-mail : webmaster[at]adk[dot]gov[dot]my

 AADK Hotline: 1-800-22-2235 / 019 – 626 2233

laman Web QRCode
REFERENCES
  • RSS Feed
  • Sitemap
  • Disclaimer
  • Privacy Policy
  • Security Policy
  • Electronic Archives
  • Credit

Updated :

  • February 22, 2022

Our Visitor

2509985
Total views : 3309615
April 2, 2023

©2021 National Anti-Drugs Agency, All Rights Reserved.
Best viewed using Mozilla Firefox 3, Internet Explorer 11, and Google Chrome with minimum resolution.

X